Stock Information
Organon & Co (OGN)
Ticker Symbol: OGN
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $3,618.64 mil
Piotroski score: 7
PE Ratio: 17.25
EPS (TTM): 0.78
Revenue (TTM): $22.65 M
Dividend Yield: 9.86%
ROE: 23.44%
Latest News
-
Organon Canada announces the Approval and Availability of NDUVRA® (tapinarof cream), 1%, a New Steroid-Free Topical Treatment for Moderate to Severe Atopic Dermatitis in Adult and Pediatric Patients 2 Years of Age and Older
Mon, Sep 28, 2026 12:01 PM
-
Organon Canada Announces Availability Of NDUVRA To Treat Moderate To Severe Atopic Dermatitis
Mon, Sep 28, 2026 8:09 AM
-
Why Organon (OGN) Is Getting Attention Today
Tue, Sep 22, 2026 12:15 PM
-
Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device
Tue, Sep 22, 2026 3:24 AM
Key Financials
Financial data not available
